Based on end user, the global IV glutathione treatment market is segmented into hospitals, specialty clinics, dermatology clinics, wellness & medical spa centers, and others
GLP-1 receptor agonists and NAION: a meta-analysis
GLP-1 Receptor Agonists More and more clinicians are using GLP-1s off-label in people with type 1 diabetes, particularly in those who also have obesity or high insulin requirements, says Mihail Zilbermint, MD, an associate professor of medicine at Johns Hopkins University School of Medicine and the chief of the division of endocrinology, diabetes, and metabolism at Suburban Hospital in Maryland
On regulatory status, the Skin Cancer Foundation has issued a public warning about this compound, Australias Therapeutic Goods Administration has urged consumers to avoid it, and its sale is illegal in the United Kingdom and restricted in a number of other jurisdictions